Finance

Lists
Why is 140410 up 2.04%?
Dive Deeper
140410:KOSDAQ
Mezzion Pharma Co Ltd
₩65,100.00
+2.04%
(+1,300.00) 1D
Nov 18, 11:31:01 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 140410...
Open
₩64,000
High
₩67,900
Low
₩64,000
Mkt. cap
2.01T
Avg. vol.
121.01K
Volume
72.55K
52-wk high
₩179,900
52-wk low
₩45,850
EPS
-₩909
Shares outstanding
30.88M
No. of employees
17
Open
₩64,000
High
₩67,900
Low
₩64,000
Mkt. cap
2.01T
Avg. vol.
121.01K
Volume
72.55K
52-wk high
₩179,900
52-wk low
₩45,850
EPS
-₩909
Shares outstanding
30.88M
No. of employees
17
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
7 hours ago
De AEX Index breekt steun
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
8 hours ago
AEX-index lager, chipbedrijven dalen in aanloop cijfers Nvidia
About Mezzion Pharma Co Ltd
CEODean Park
Employees17
Founded2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.13B
2.08B
2.02B
2.20B
Cost of goods sold
1.74B
1.79B
1.67B
1.80B
Cost of revenue
1.74B
1.79B
1.67B
1.80B
Research and development expenses
129.68M
449.03M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.67B
4.74B
4.69B
4.73B
Operating expense
5.04B
5.42B
4.91B
4.94B
Total operating expenses
6.78B
7.21B
6.58B
6.74B
Operating income
-4.65B
-5.12B
-4.56B
-4.54B
Other non operating income
-46.91M
-20.91B
-31.55M
16.37B
EBT including unusual items
-5.13B
-26.59B
-5.31B
7.69B
EBT excluding unusual items
-5.16B
-26.59B
-5.31B
11.00B
Income tax expense
-
-1.95B
-
-
Effective tax rate
-
7.34%
-
-
Other operating expenses
-
-
-
-
Net income
-5.13B
-24.64B
-5.31B
7.69B
Net profit margin
-241.07%
-1,182.14%
-263.34%
349.19%
Earnings per share
-
-
-
-
Interest and investment income
195.74M
177.15M
44.40M
282.77M
Interest expense
-646.50M
-722.23M
-736.54M
-1.10B
Net interest expenses
-450.76M
-545.08M
-692.14M
-817.20M
Depreciation and amortization charges
240.38M
234.72M
195.06M
212.76M
EBITDA
-4.41B
-4.89B
-4.37B
-4.33B
Gain or loss from assets sale
-31.26M
-209.00K
-
-24.48M
Upcoming events
AI content may include mistakes. Learn more
Google apps